SPP1 and Hepatic fibrosis: Engulfing OPN-small interference RNA (siRNA) into EVs isolated from ADSCs and injecting them into CCl4-induced liver fibrosis models can reverse HSC activation and ECM deposition, thereby mitigating liver fibrosis and increasing liver function [134].